Amalgamated Bank’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $265K | Sell |
8,107
-814
| -9% | -$29.3K | ﹤0.01% | 1532 |
|
|
2026
Q1 | $315K | Sell |
8,921
-79
| -0.9% | -$3.21K | ﹤0.01% | 1456 |
|
|
2025
Q4 | $365K | Sell |
9,000
-129
| -1% | -$5.61K | ﹤0.01% | 1425 |
|
|
2025
Q3 | $429K | Buy |
9,129
+294
| +3% | +$15.2K | ﹤0.01% | 1367 |
|
|
2025
Q2 | $460K | Hold |
8,835
| – | – | ﹤0.01% | 1304 |
|
|
2025
Q1 | $534K | Sell |
8,835
-234
| -3% | -$15.1K | ﹤0.01% | 1232 |
|
|
2024
Q4 | $621K | Hold |
9,069
| – | – | 0.01% | 1230 |
|
|
2024
Q3 | $652K | Sell |
9,069
-337
| -4% | -$23.8K | 0.01% | 1207 |
|
|
2024
Q2 | $652K | Sell |
9,406
-133
| -1% | -$9.7K | 0.01% | 1196 |
|
|
2024
Q1 | $764K | Sell |
9,539
-3,695
| -28% | -$329K | 0.01% | 1152 |
|
|
2023
Q4 | $1.45M | Sell |
13,234
-349
| -3% | -$36.1K | 0.01% | 1012 |
|
|
2023
Q3 | $1.37M | Sell |
13,583
-307
| -2% | -$35.3K | 0.01% | 1004 |
|
|
2023
Q2 | $1.89M | Buy |
13,890
+70
| +0.5% | +$8.55K | 0.02% | 915 |
|
|
2023
Q1 | $1.44M | Sell |
13,820
-910
| -6% | -$88K | 0.01% | 985 |
|
|
2022
Q4 | $1.31M | Sell |
14,730
-43
| -0.3% | -$3.57K | 0.01% | 1049 |
|
|
2022
Q3 | $1.18M | Buy |
14,773
+747
| +5% | +$70.5K | 0.01% | 1044 |
|
|
2022
Q2 | $1.34M | Sell |
14,026
-244
| -2% | -$29.3K | 0.01% | 1030 |
|
|
2022
Q1 | $2.12M | Sell |
14,270
-756
| -5% | -$106K | 0.02% | 907 |
|
|
2021
Q4 | $2.13M | Sell |
15,026
-301
| -2% | -$42.6K | 0.02% | 915 |
|
|
2021
Q3 | $2M | Sell |
15,327
-271
| -2% | -$35.5K | 0.02% | 925 |
|
|
2021
Q2 | $2.14M | Buy |
15,598
+11,479
| +279% | +$1.57M | 0.02% | 932 |
|
|
2021
Q1 | $538K | Sell |
4,119
-376
| -8% | -$45.3K | 0.02% | 934 |
|
|
2020
Q4 | $503K | Buy |
4,495
+41
| +0.9% | +$3.88K | 0.02% | 969 |
|
|
2020
Q3 | $350K | Sell |
4,454
-147
| -3% | -$12K | 0.02% | 1031 |
|
|
2020
Q2 | $331K | Sell |
4,601
-506
| -10% | -$35.2K | 0.02% | 1056 |
|
|
2020
Q1 | $292K | Sell |
5,107
-199
| -4% | -$18.4K | 0.01% | 1164 |
|
|
2019
Q4 | $593K | Buy |
5,306
+264
| +5% | +$28.1K | 0.01% | 1039 |
|
|
2019
Q3 | $485K | Sell |
5,042
-86
| -2% | -$8.07K | 0.01% | 1051 |
|
|
2019
Q2 | $439K | Buy |
5,128
+1,264
| +33% | +$104K | 0.01% | 1141 |
|
|
2019
Q1 | $321K | Buy |
3,864
+105
| +3% | +$7.63K | 0.01% | 1229 |
|
|
2018
Q4 | $241K | Buy |
3,759
+812
| +28% | +$55.6K | 0.01% | 1305 |
|
|
2018
Q3 | $233K | Sell |
2,947
-889
| -23% | -$68.8K | 0.01% | 1247 |
|
|
2018
Q2 | $281K | Sell |
3,836
-38
| -1% | -$2.58K | 0.01% | 1361 |
|
|
2018
Q1 | $245K | Sell |
3,874
-56
| -1% | -$3.34K | 0.01% | 1339 |
|
|
2017
Q4 | $200K | Buy |
+3,930
| New | +$205K | 0.01% | 1505 |
|
Other funds holding CNMD
CB
GT
TCM
Amalgamated Bank's CNMD Position: Q2 2026 in Review
Amalgamated Bank reduced its CONMED (CNMD) stake by 9.1% in Q2 2026, selling an estimated $29.3K and leaving 8,107 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1532.
Amalgamated Bank first reported a position in CNMD in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.14M in Q2 2021. 101 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Amalgamated Bank held 8,107 shares of CONMED worth $265K as of Q2 2026.
- Amalgamated Bank sold 814 CONMED shares in Q2 2026, an estimated $29.3K.
- CONMED made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1532 holding.
- Amalgamated Bank first reported a position in CONMED in Q4 2017 and has held it in 35 quarters since.
- Amalgamated Bank's CONMED position peaked at $2.14M in Q2 2021.
- 101 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.